Example: Heart Attack

Search clinical trials for: Modulation of FiO2

Total 10000 results

NCT01579760

Completed

Intravitreal Aflibercept Injection for Radiation Retinopathy

Macular Edema | Radiation Retinopathy
NCT03616691

Unknown

Atezolizumab Monotherapy and Consequent Therapy With Atezolizumab Plus Bevacizumab for NSCLC

Non Small Cell Lung Cancer
NCT00949364

Completed

Pomalidomide in Patients With Myeloproliferative Neoplasms in Fibrotic Stage

Myeloproliferative Neoplasms
NCT01068977

Completed

A Study of the Safety and Pharmacology of MetMAb (PRO143966), a Monovalent Antagonist Antibody to the Receptor C-Met, Administered Intravenously in Patients With Locally Advanced or Metastatic Solid Tumors

Solid Cancers
NCT01657461

Completed

Solitaire™ With the Intention For Thrombectomy as PRIMary Endovascular Treatment (SWIFT PRIME) Trial (SWIFT PRIME)

Acute Ischemic Stroke
NCT02260414

Completed

Effects of Anticoagulant Preventive Injection in Patients With Blood Cancer (METRO B)

Lymphoma | Multiple Myeloma
NCT02125318

Completed

A Study of Anagrelide Controlled Release (GALE-401) in Patients With High Platelet Counts Due to Bone Marrow Disorders

Thrombocytosis | Myeloproliferative Neoplasms
NCT00849459

Completed

Gene Therapy in Treating Women With Metastatic Breast Cancer

Breast Cancer
NCT00642824

Terminated

A Genetic Substudy Associated With the Avastin (Bevacizumab) Study MO19390 in Patients With Advanced or Recurrent Non-Squamous Cell Lung Cancer.

Non-Squamous Non-Small Cell Lung Cancer
NCT00416637

Completed

Bevacizumab in Treating Patients With Advanced Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific
NCT01462968

Withdrawn

Interruptions in the Coagulationsystem in Relation With Cardiac Surgery - A Study Comparing Two Heparinization Strategies During On-pump Cardiac Surgery

Cardiac Surgery
NCT01133665

Completed

Cetuximab and Lenalidomide in Head and Neck

Squamous Cell Carcinoma
NCT02005120

Unknown

Intrapleural Administration of Bevacizumab Versus Endostar for Pleural Effusions in NSCLC

Non Small Cell Lung Cancer
NCT00931125

Unknown

Safety and Efficacy of Intravitreal Ranibizumab as a Preoperative Adjunct Treatment Before Vitrectomy Surgery in Proliferative Diabetic Retinopathy (PDR) Compared to Vitrectomy Alone (VITARM)

Diabetic Retinopathy
NCT00910858

Completed

A Pharmacokinetic And Pharmacodynamic Study Of Oral Lenalidomide (Revlimid) In Subjects With Low- Or Intermediate-1-Risk Myelodysplastic Syndromes

Low- or Intermediate-1-risk Myelodysplastic Syndrome (MDS)
NCT01200212

Terminated

A Randomized Study to Determine the Efficacy of a Taxane and Bevacizumab With or Without Capecitabine as First Line Chemotherapy in Patients With Metastatic Breast Cancer (TABEA)

Breast Cancer
NCT01363193

Unknown

Safety and Efficacy of Lean Body Weight-based IV Heparin Dosing in Obese/Morbidly Obese Patients

Obesity | Atrial Fibrillation | Chest Pain | Venous Thromboembolism | Morbid Obesity | Angina
NCT00714597

Terminated

Evaluation of AVE5026 in the Prevention of Venous Thromboembolism in Acutely Ill Medical Patients With Restricted Mobility (SAVE-VEMED)

Venous Thromboembolism
NCT01086046

Unknown

Study of Blood Clotting After Transcatheter Atrial Septal Defect Closure

Thrombosis
NCT00284050

Completed

Safety and Efficacy of Ranibizumab in Diabetic Macular Edema With Center Involvement (RESOLVE)

Diabetic Macular Edema
NCT03431987

Recruiting

Neuroscience of Alcohol and Marijuana Impaired Driving

Alcohol Drinking | Marijuana Usage
NCT01050790

Completed

Lenalidomide + Azacitidine for Adaptive Immunotherapy -> Auto SCT in Multiple Myeloma

Multiple Myeloma
NCT00371111

Unknown

To Compare Therapeutic Effect of Intravitreal Bevacizumab and Triamcinolone in Resistant Uveitic Cystoid Macular Edema

Resistant Cystoid Macular Edema
NCT05290948

Active, not recruiting

Comparison of Combined Intravitreal Bevacizumab and Oral Acetazolamide Versus Intravitreal Bevacizumab Alone for the Treatment of Macular Edema Secondary to Retinal Vein Occlusions

Macular Edema
NCT07464093

Recruiting

STABLE Pilates for Hypermobility (STABLE)

Hypermobile EDS (hEDS) | Ehlers-Danlos Syndrome (EDS) | Hypermobile Spectrum Disorder
NCT03478540

Unknown

Gut Microbiota and Immune Recovery

HIV-1-infection
NCT01366651

Terminated

A Study of Doripenem in CerebrospinalFluid After Doripenem Administration in Pediatric Patients Less Than 1 Year of Age

Meningitis
NCT01408030

Completed

North American Study of Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT) (NOSE)

Epistaxis | Telangiectasia, Hereditary Hemorrhagic
NCT00053131

Completed

Combination Chemotherapy Followed By Filgrastim or Sargramostim in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia

Leukemia
NCT07026838

Active, not recruiting

Advancing Family Wellbeing Through a Massive Open Online Intervention: The LightBEAM Program

Anger | Parenting | Child Development | Depression, Anxiety | Stress Psychological | Parent Child Relationship
NCT07192718

Enrolling by invitation

Using Empowered Relief and Education To Help Postpartum Women Recover After Cesarean Delivery

Cesarean Section Complications | Postpartum Care
NCT04891107

Completed

Feasibility and Preliminary Effects of MR-005 in Persons With Parkinson Disease

Parkinson Disease
NCT02974816

Completed

Glooko mHealth Advantage Study

Diabetes Mellitus, Type 2
NCT06650709

Not yet recruiting

NEoadjuvant Olaparib Combination OvArian Cancer Targeted Study (NEOCATS)

Ovarian Cancer Stage IV
NCT05638451

Recruiting

Sintilimab in Combination With Bevacizumab and Temozolomide in Recurrent Glioblastoma (GBM) Patients

Recurrent Glioblastoma
NCT04733963

Recruiting

Fruquintinib Plus Capecitabine Versus Bevacizumab Plus Capecitabine as Maintenance Therapy Following First-line Treatment for Metastatic Colorectal Cancer

Colorectal Cancer
NCT04224636

Recruiting

Atezolizumab/Bevacizumab Followed by On-demand TACE or Initial Synchronous Treatment With TACE and Atezolizumab/Bevacizumab (DEMAND)

Hepatocellular Carcinoma Non-resectable
NCT03025893

Recruiting

A Phase II/III Study of High-dose, Intermittent Sunitinib in Patients With Recurrent Glioblastoma Multiforme (STELLAR)

Glioblastoma | Glioblastoma Multiforme | GBM | Glioblastoma, Adult | Recurrent Brain Tumor
NCT00437372

Completed

Phase IB Study Using Sunitinib Plus Radiation Therapy for Cancer Patients

Cancer | Head and Neck Cancer | Thoracic Neoplasms | Nervous System Neoplasms | Pelvic Cancer
NCT05022927

Active, not recruiting

A Phase I Study of ERY974 in Patients With Hepatocellular Carcinoma

Hepatocellular Carcinoma (HCC)
NCT03689855

Completed

Ramucirumab and Atezolizumab After Progression on Any Immune Checkpoint Blocker in NSCLC (RamAtezo-1)

NSCLC | Non Small Cell Lung Cancer | Non-small Cell Lung Cancer
NCT04541173

Terminated

Study of Atezolizumab and Bevacizumab With Y-90 TARE in Patients With Unresectable Hepatocellular Carcinoma (HCC)

Hepatocellular Carcinoma
NCT04723004

Active, not recruiting

Evaluate the Safety and Efficacy of Toripalimab Combined With Bevacizumab Versus Sorafenib Therapy for HCC

Advanced Hepatocellular Carcinoma (HCC)
NCT04194359

Active, not recruiting

Sintilimab (IBI308) Combined With Bevacizumab + XELOX Regimen in Metastatic Colorectal Cancer

Metastatic Colorectal Cancer | Microsatellite Stable | RAS Mutation
NCT04656067

Completed

Comparative Study Between Oxytocin Versus Tranexamic Acid and Ethamsylate

Blood Loss, Surgical | Blood Loss, Postoperative
NCT04741165

Unknown

Study of HX008 in Combination With Bevacizumab or Lenvatinib for the Treatment of Advanced Hepatocellular Carcinoma (HCC)

Hepatocellular Carcinoma
NCT01379274

Terminated

A Trial of Lenalidomide & Azacitidine in Low Risk Myelodysplastic Syndromes

MDS
NCT02315625

Terminated

Study of Mutation-Targeted Therapy With Sunitinib or Everolimus in People With Advanced Low- or Intermediate-Grade Neuroendocrine Tumors of the Gastrointestinal Tract and Pancreas With or Without Cytoreductive Surgery

Neuroendocrine Tumors | Carcinoma, Neuroendocrine | Neuroendocrine Carcinoma | Neuroendocrine Neoplasms | Neuroendocrine Tumors of the Gastrointestinal Tract and Pancreas
NCT01005472

Completed

Temozolomide and Sunitinib Malate in Treating Patients With Stage III or Stage IV Malignant Melanoma

Metastatic Melanoma
NCT00436332

Completed

S0635: Erlotinib and Bevacizumab in Stage IIIB and IV Bronchioloalveolar Carcinoma

Lung Cancer

Search clinical trials for: Modulation of FiO2

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations